NorthWest Biotherapeutics Inc (NWBO)

[DownWithPumpers]

It's what's wrong with 99% of the discussion of efficacy.

The #1 factor determining whether someone has had an event is their age. That's the most obvious thing in the world. Yet I've seen no analysis at all along those lines.

Obviously real investors who have decided not to buy this stock have considered it.

The second important factor that's often overlooked is that the current SOC costs over 20K a month, and how fast is a drug that significantly adds to that cost going to sell?